# Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.

> **NCT06813027** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Jordan** · enrollment: 13 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **BIOLOGICAL:** EV

## Key facts

- **NCT ID:** NCT06813027
- **Lead sponsor:** University of Jordan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2026-01-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06813027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06813027, "Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06813027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*